Nephrotoxicity of Amphotericin B
- 1 December 1963
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 112 (6) , 853-862
- https://doi.org/10.1001/archinte.1963.03860060091009
Abstract
Introduction The nephrotoxicity associated with amphotericin B has beeen the greatest deterrent to its effective use1-6 in the treatment of systemic mycoses. The precise nature of this toxicity is obscure, and the available descriptions are conflicting. The present report is a study of renal function and morphology during amphotericin B therapy for Coccidioides immitis infections. Material and Methods Six patients with clinical and serologic evidence of disseminated coccidioidomycosis were studied before, during, and after therapy. Two of the patients had no previous treatment. The other four had prior amphotericin B therapy. Clinical details, including cumulative dosages, appear in Tables 1 and 2. Diagnosis of dissemination was based on isolation of C immitis from an extrapulmonary site or a maximum complement fixation titer of at least 1:32 (see Table 1). The diagnosis of coccidioidal meningitis was confirmed by the criteria employed by Einstein et al,7 ie, spinal fluid findingsThis publication has 4 references indexed in Scilit:
- Renal Disease and the Metabolic Effects of TetracyclineAnnals of Internal Medicine, 1963
- A Therapeutic DilemmaAnnals of Internal Medicine, 1962
- THE TREATMENT OF SYSTEMIC FUNGUS INFECTIONS WITH AMPHOTERICIN B*Annals of the New York Academy of Sciences, 1960
- The Treatment of Deep Mycotic Infections with Amphotericin B1American Review of Respiratory Disease, 1960